Current Evidence, Tools, and Resources to Optimize Outcomes for Patients With Renal Cell Carcinoma

Improve your ability to provide individualized, evidence-based treatment of renal cell carcinoma through a CME/CE/CPE-certified text module, an Interactive Decision Support Tool with case-specific recommendations, and expert commentaries.


Program Content


RCC Outcomes Optimization
Optimizing Outcomes for Patients With RCC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: April 07, 2023

Expires: April 06, 2024

View Activity


RCC Treatment Support Tool
Treatment Decision Support Tool Enhances Therapy Considerations for Metastatic Clear Cell RCC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2023

View Activity


cover img faculity

Katy Beckermann, MD, PhD

Assistant Professor
Department of Internal Medicine
Division of Hematology/Oncology
Vanderbilt University
Nashville, Tennessee

cover img faculity

Wenxin Xu, MD

Instructor of Medicine
Lank Center for Genitourinary Oncology
Medical Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC


Supported by educational grants from AVEO Pharmaceuticals, Inc.; Bristol Myers Squibb; and Exelixis, Inc.

AVEO Pharmaceuticals, Inc.

Bristol Myers Squibb

Exelixis, Inc.